Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study

Objective:. To create and validate nomograms predicting overall survival and recurrence in treatment-naïve rectal cancer (RC) patients who underwent upfront surgery. Background:. Although multidisciplinary treatment is standard for locally advanced RC, understanding surgical efficacy is important fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Yukihide Kanemitsu, MD, Tomofumi Uotani, MD, Shunsuke Tsukamoto, PhD, Hideki Ueno, PhD, Megumi Ishiguro, PhD, Soichiro Ishihara, PhD, Koji Komori, PhD, Kenichi Sugihara, PhD, Study Group for Nomogram of the Japanese Society for Cancer of the Colon and Rectum
Format: Article
Language:English
Published: Wolters Kluwer Health 2024-12-01
Series:Annals of Surgery Open
Online Access:http://journals.lww.com/10.1097/AS9.0000000000000508
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589724738387968
author Yukihide Kanemitsu, MD
Tomofumi Uotani, MD
Shunsuke Tsukamoto, PhD
Hideki Ueno, PhD
Megumi Ishiguro, PhD
Soichiro Ishihara, PhD
Koji Komori, PhD
Kenichi Sugihara, PhD
Study Group for Nomogram of the Japanese Society for Cancer of the Colon and Rectum
author_facet Yukihide Kanemitsu, MD
Tomofumi Uotani, MD
Shunsuke Tsukamoto, PhD
Hideki Ueno, PhD
Megumi Ishiguro, PhD
Soichiro Ishihara, PhD
Koji Komori, PhD
Kenichi Sugihara, PhD
Study Group for Nomogram of the Japanese Society for Cancer of the Colon and Rectum
author_sort Yukihide Kanemitsu, MD
collection DOAJ
description Objective:. To create and validate nomograms predicting overall survival and recurrence in treatment-naïve rectal cancer (RC) patients who underwent upfront surgery. Background:. Although multidisciplinary treatment is standard for locally advanced RC, understanding surgical efficacy is important for determining indications for perioperative adjuvant therapy. Methods:. RC patients who underwent upfront surgery at the Japanese Society for Cancer of the Colon and Rectum institutions were analyzed. A training cohort (n = 1925) of treatment-naïve patients who underwent surgery between 2007 and 2008 was analyzed to construct prognostic models predicting postoperative survival and recurrence. Discrimination and calibration were performed using an external validation cohort (n = 2957; Japanese colorectal cancer registry, procedures in 2005–2006). Effects of adjuvant chemotherapy on survival were evaluated based on nomogram prediction and Surveillance, Epidemiology, and End Results (SEER) data (n = 10,482; upfront surgery for RC in 2010–2015). Results:. In the training cohort, age predicted survival, venous invasion predicted recurrence, and sex, tumor location, histological type, preoperative carcinoembryonic antigen, invasion depth, lymphatic invasion, positive radial margin, and numbers of metastatic nodes and examined nodes predicted both. Internal and external validated Harrell’s C-index values were respectively 0.77 and 0.75 for survival and 0.75 and 0.74 for recurrence. RC patients who underwent upfront surgery in the SEER database were stratified into 3 risk levels by nomogram score. Adjuvant chemotherapy did not improve 5-year survival in low-risk patients, but did so for middle-risk (62.4% vs 76.8%) and high-risk (39.4% vs 63.5%) patients. Conclusion:. These nomograms could predict survival and recurrence after upfront curative resection of RC and identify cases expected to benefit more from adjuvant chemotherapy.
format Article
id doaj-art-c2cecc8f83d34d65a79d38f4bca2070d
institution Kabale University
issn 2691-3593
language English
publishDate 2024-12-01
publisher Wolters Kluwer Health
record_format Article
series Annals of Surgery Open
spelling doaj-art-c2cecc8f83d34d65a79d38f4bca2070d2025-01-24T09:18:58ZengWolters Kluwer HealthAnnals of Surgery Open2691-35932024-12-0154e50810.1097/AS9.0000000000000508202412000-00023Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional studyYukihide Kanemitsu, MD0Tomofumi Uotani, MD1Shunsuke Tsukamoto, PhD2Hideki Ueno, PhD3Megumi Ishiguro, PhD4Soichiro Ishihara, PhD5Koji Komori, PhD6Kenichi Sugihara, PhD7Study Group for Nomogram of the Japanese Society for Cancer of the Colon and RectumFrom the * Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, JapanFrom the * Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, JapanFrom the * Department of Colorectal Surgery, National Cancer Center Hospital, Tokyo, Japan† Department of Surgery, National Defense Medical College, Saitama, Japan‡ Health Science Research and Development Center, Tokyo Medical and Dental University (TMDU), Tokyo, Japan§ Department of Surgical Oncology, The University of Tokyo, Tokyo, Japan‖ Department of Gastroenterological Surgery, Aichi Cancer Center, Hospital, Nagoya, Japan¶ Tokyo Medical and Dental University, The University of Tokyo, Tokyo, Japan.Objective:. To create and validate nomograms predicting overall survival and recurrence in treatment-naïve rectal cancer (RC) patients who underwent upfront surgery. Background:. Although multidisciplinary treatment is standard for locally advanced RC, understanding surgical efficacy is important for determining indications for perioperative adjuvant therapy. Methods:. RC patients who underwent upfront surgery at the Japanese Society for Cancer of the Colon and Rectum institutions were analyzed. A training cohort (n = 1925) of treatment-naïve patients who underwent surgery between 2007 and 2008 was analyzed to construct prognostic models predicting postoperative survival and recurrence. Discrimination and calibration were performed using an external validation cohort (n = 2957; Japanese colorectal cancer registry, procedures in 2005–2006). Effects of adjuvant chemotherapy on survival were evaluated based on nomogram prediction and Surveillance, Epidemiology, and End Results (SEER) data (n = 10,482; upfront surgery for RC in 2010–2015). Results:. In the training cohort, age predicted survival, venous invasion predicted recurrence, and sex, tumor location, histological type, preoperative carcinoembryonic antigen, invasion depth, lymphatic invasion, positive radial margin, and numbers of metastatic nodes and examined nodes predicted both. Internal and external validated Harrell’s C-index values were respectively 0.77 and 0.75 for survival and 0.75 and 0.74 for recurrence. RC patients who underwent upfront surgery in the SEER database were stratified into 3 risk levels by nomogram score. Adjuvant chemotherapy did not improve 5-year survival in low-risk patients, but did so for middle-risk (62.4% vs 76.8%) and high-risk (39.4% vs 63.5%) patients. Conclusion:. These nomograms could predict survival and recurrence after upfront curative resection of RC and identify cases expected to benefit more from adjuvant chemotherapy.http://journals.lww.com/10.1097/AS9.0000000000000508
spellingShingle Yukihide Kanemitsu, MD
Tomofumi Uotani, MD
Shunsuke Tsukamoto, PhD
Hideki Ueno, PhD
Megumi Ishiguro, PhD
Soichiro Ishihara, PhD
Koji Komori, PhD
Kenichi Sugihara, PhD
Study Group for Nomogram of the Japanese Society for Cancer of the Colon and Rectum
Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
Annals of Surgery Open
title Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
title_full Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
title_fullStr Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
title_full_unstemmed Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
title_short Nomograms Predicting Survival, Recurrence and Beneficiary Identification of Adjuvant Chemotherapy in Treatment-naïve Patients with Rectal Cancer who Underwent Upfront Curative Resection: A multi-institutional study
title_sort nomograms predicting survival recurrence and beneficiary identification of adjuvant chemotherapy in treatment naive patients with rectal cancer who underwent upfront curative resection a multi institutional study
url http://journals.lww.com/10.1097/AS9.0000000000000508
work_keys_str_mv AT yukihidekanemitsumd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT tomofumiuotanimd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT shunsuketsukamotophd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT hidekiuenophd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT megumiishigurophd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT soichiroishiharaphd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT kojikomoriphd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT kenichisugiharaphd nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy
AT studygroupfornomogramofthejapanesesocietyforcancerofthecolonandrectum nomogramspredictingsurvivalrecurrenceandbeneficiaryidentificationofadjuvantchemotherapyintreatmentnaivepatientswithrectalcancerwhounderwentupfrontcurativeresectionamultiinstitutionalstudy